Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis

Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis

Yiqun Han,1 Jiayu Wang,1 Weiming Liu,2 Peng Yuan,1 Qing Li,1 Pin Zhang,1 Fei Ma,1 Yang Luo,1 Ying Fan,1 Shanshan Chen,1 Ruigang Cai,1 Qiao Li,1 Binghe Xu11National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical...

Full description

Bibliographic Details
Main Authors: Han Y, Wang J, Liu W, Yuan P, Li Q, Zhang P, Ma F, Luo Y, Fan Y, Chen S, Cai R, Xu B
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Cancer Management and Research
Subjects:
trastuzumab
retreatment
HER2-positive cancer
metastatic cancer of the breast
progression therapy
Online Access:https://www.dovepress.com/trastuzumab-treatment-after-progression-in-her2-positive-metastatic-br-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/trastuzumab-treatment-after-progression-in-her2-positive-metastatic-br-peer-reviewed-article-CMAR

Similar Items